BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21745178)

  • 1. Integrase-defective lentiviral vectors--a stage for nonviral integration machineries.
    Staunstrup NH; Mikkelsen JG
    Curr Gene Ther; 2011 Oct; 11(5):350-62. PubMed ID: 21745178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase.
    Moldt B; Staunstrup NH; Jakobsen M; Yáñez-Muñoz RJ; Mikkelsen JG
    BMC Biotechnol; 2008 Aug; 8():60. PubMed ID: 18691430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid lentivirus-transposon vectors with a random integration profile in human cells.
    Staunstrup NH; Moldt B; Mátés L; Villesen P; Jakobsen M; Ivics Z; Izsvák Z; Mikkelsen JG
    Mol Ther; 2009 Jul; 17(7):1205-14. PubMed ID: 19240688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-integrating lentiviral vectors.
    Sarkis C; Philippe S; Mallet J; Serguera C
    Curr Gene Ther; 2008 Dec; 8(6):430-7. PubMed ID: 19075626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.
    Nordin F; Hamid ZA; Chan L; Farzaneh F; Hamid MK
    Methods Mol Biol; 2016; 1448():159-73. PubMed ID: 27317180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.
    Moldt B; Miskey C; Staunstrup NH; Gogol-Döring A; Bak RO; Sharma N; Mátés L; Izsvák Z; Chen W; Ivics Z; Mikkelsen JG
    Mol Ther; 2011 Aug; 19(8):1499-510. PubMed ID: 21468003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted, homology-driven gene insertion in stem cells by ZFN-loaded 'all-in-one' lentiviral vectors.
    Cai Y; Laustsen A; Zhou Y; Sun C; Anderson MV; Li S; Uldbjerg N; Luo Y; Jakobsen MR; Mikkelsen JG
    Elife; 2016 Jun; 5():. PubMed ID: 27278774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrase defective, nonintegrating lentiviral vectors.
    Michelini Z; Negri D; Cara A
    Methods Mol Biol; 2010; 614():101-10. PubMed ID: 20225038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.
    Pelascini LP; Janssen JM; Gonçalves MA
    Hum Gene Ther; 2013 Jan; 24(1):78-96. PubMed ID: 23140481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.
    Chick HE; Nowrouzi A; Fronza R; McDonald RA; Kane NM; Alba R; Delles C; Sessa WC; Schmidt M; Thrasher AJ; Baker AH
    Hum Gene Ther; 2012 Dec; 23(12):1247-57. PubMed ID: 22931362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrase-deficient lentivirus: opportunities and challenges for human gene therapy.
    Liu KC; Lin BS; Gao AD; Ma HY; Zhao M; Zhang R; Yan HH; Yi XF; Lin SJ; Que JW; Lan XP
    Curr Gene Ther; 2014; 14(5):352-64. PubMed ID: 25174579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleeping beauty transposition from nonintegrating lentivirus.
    Vink CA; Gaspar HB; Gabriel R; Schmidt M; McIvor RS; Thrasher AJ; Qasim W
    Mol Ther; 2009 Jul; 17(7):1197-204. PubMed ID: 19417741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel integrase-defective lentiviral episomal vectors for gene transfer.
    Vargas J; Gusella GL; Najfeld V; Klotman ME; Cara A
    Hum Gene Ther; 2004 Apr; 15(4):361-72. PubMed ID: 15053861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrase-defective lentiviral vectors: progress and applications.
    Banasik MB; McCray PB
    Gene Ther; 2010 Feb; 17(2):150-7. PubMed ID: 19847206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.
    Philippe S; Sarkis C; Barkats M; Mammeri H; Ladroue C; Petit C; Mallet J; Serguera C
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17684-9. PubMed ID: 17095605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for retargeted gene delivery using vectors derived from lentiviruses.
    Bartosch B; Cosset FL
    Curr Gene Ther; 2004 Dec; 4(4):427-43. PubMed ID: 15578992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration-deficient lentiviral vectors: a slow coming of age.
    Wanisch K; Yáñez-Muñoz RJ
    Mol Ther; 2009 Aug; 17(8):1316-32. PubMed ID: 19491821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.
    Okada Y; Ueshin Y; Hasuwa H; Takumi K; Okabe M; Ikawa M
    Genesis; 2009 Apr; 47(4):217-23. PubMed ID: 19208434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditionally replicating lentiviral-hybrid episomal vectors for suicide gene therapy.
    Vargas J; Klotman ME; Cara A
    Antiviral Res; 2008 Dec; 80(3):288-94. PubMed ID: 18647620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.
    Hanoun N; Gayral M; Pointreau A; Buscail L; Cordelier P
    Hum Gene Ther; 2016 Feb; 27(2):184-92. PubMed ID: 26731312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.